MedPath

Revealing Increased Axonal Loss in Treated HIV Patients

Completed
Conditions
HIV Seropositivity
Interventions
Other: ophthalmologic examination and MRI
Registration Number
NCT02003989
Lead Sponsor
Fondation Ophtalmologique Adolphe de Rothschild
Brief Summary

HIV patients may suffer sooner from aging than average population, including brain aging. Our hypothesis is that if brain dysfunctions are explained by a quicker loss of neurons in HIV patients, this loss could be detected earlier by a thinning down of retinal nerve fiber layer (RNFL), compared to non HIV patients of the same age.

Detailed Description

The investigators aim to compare the thickness of the RNFL and the thickness of the RCGs measured by spectral domain OCT between patients infected by HIV and patients of same age non infected by HIV.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
156
Inclusion Criteria
  • HIV infection known since at least 10 years
  • viral load undetectable under ARV treatment since at least 5 years, whatever the type of ARV
  • lymphocytes CD4 > 350, whatever the CD4 nadir
  • signed informed consent
Exclusion Criteria
  • History of ocular pathology, eye surgery, or intraocular injection
  • Familial History of glaucoma
  • ametropia (>3 dioptres on the sphere and >1,5 dioptres on the cylinder)
  • known neurological pathology, active or former
  • History of ethambutol or synthetic antimalarial drug consumption
  • History of chemotherapy
  • Active and regular use of drugs
  • non-weaned chronic alcoholism
  • contra indication to MRI
  • diabetes
  • cognitive disorders (MoCA<26)
  • non covered by health insurance
  • patient under legal protection
  • pregnant or breast-feeding woman
  • Non inclusion criteria for control patients: known HIV infection

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
controlophthalmologic examination and MRInon HIV patients (same gender and age) undergoing ophthalmologic examination and MRI
patientsophthalmologic examination and MRIHIV patients infected for more than ten years with undetectable viral load, undergoing ophthalmologic examination and MRI
Primary Outcome Measures
NameTimeMethod
thickness of the RNFL and the RCGs measured by spectral domain OCT, between the two groups of patientsone day of examinations
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Fondation OPH A de Rothschild

🇫🇷

Paris, Ile de France, France

© Copyright 2025. All Rights Reserved by MedPath